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ABSTRACT  
In addition to playing a role in adhesion, desmoglein 2 (Dsg2) is an important regulator of 
growth and survival signaling pathways, cell proliferation, migration and invasion, and 
oncogenesis.  While low-level Dsg2 expression is observed in basal keratinocytes and is 
downregulated in non-healing venous ulcers, overexpression has been observed in both 
melanomas and non-melanoma malignancies.  Here, we show that transgenic mice 
overexpressing Dsg2 in basal keratinocytes primed the activation of mitogenic pathways, but did 
not induce dramatic epidermal changes or susceptibility to chemical-induced tumor 
development.  Interestingly, acceleration of full-thickness wound closure and increased wound-
adjacent keratinocyte proliferation was observed in these mice.  As epidermal cytokines and their 
receptors play critical roles in wound healing, Dsg2-induced secretome alterations were assessed 
with an antibody profiler array and revealed increased release and proteolytic processing of the 
urokinase-type plasminogen activator receptor (uPAR). Dsg2 induced uPAR expression in the 
skin of transgenic compared to wild-type mice. Wound healing further enhanced uPAR in both 
epidermis and dermis with concomitant increase in the pro-healing laminin-332, a major 
component of the basement membrane zone, in transgenic mice.  This study demonstrates that 
Dsg2 induces epidermal activation of various signaling cascades and accelerates cutaneous 
wound healing, in part, through uPAR-related signaling cascades. 
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INTRODUCTION 
Epidermal keratinocytes undergo orchestrated proliferation and differentiation that is intricately 
regulated by crosstalk between the dermis and epidermis (Dhouailly and Sawyer, 1984).  
Disruption of homeostasis during wound healing requires coordinated activation of signaling 
cascades to facilitate.  Stem-like basal keratinocytes divide asymmetrically into one 
differentiating and one basal/proliferative keratinocyte to maintain the stratification of the self-
renewing epidermis (Lechler and Fuchs, 2005, Roshan et al., 2016).  Keratinocytes adjacent to 
the wounds express basal-like and ‘activated’ cytokeratins and stem-like transcription factors, 
including Slug (Aomatsu et al., 2012, McGowan and Coulombe, 1998).  It is paramount to the 
intrinsic self-renewal capabilities of the skin to maintain basal keratinocytes in a pro-proliferative 
state and responsive to migratory signals. 
Signaling mediated by adhesion proteins is emerging as a key player in maintaining 
epidermal homeostasis and function (Kowalczyk and Green, 2013).  The desmosomal cadherin 
desmoglein 2 (Dsg2) has been shown to play a critical role in cell proliferation and migration.  
Embryonic lethal Dsg2-/- mice illustrate that Dsg2 is essential for developmental cell survival and 
growth (Eshkind et al., 2002).  Transgenic overexpression of Dsg2 in suprabasal epidermis 
enhances activation of mitogenic signaling pathways and increases keratinocyte proliferation, 
resulting in epidermal hyperplasia and enhanced susceptibility to tumor growth (Brennan et al., 
2007).  How Dsg2 modulates mitogenic signaling may involve its localization to lipid rafts and 
interaction with caveolin-1, an integral membrane component and signal regulator of lipid rafts 
(Brennan et al., 2012).  Dsg2 also modulates EGFR levels and activation, promoting increased 
cell proliferation, migration, and invasion (Klessner et al., 2009, Overmiller et al., 2016).  
Furthermore, Dsg2 upregulates Gli1 and Ptch1, target genes of the Hh signaling pathway, and 
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compound Dsg2/Ptc1+/lacZ mice have accelerated development of basal and squamous cell 
carcinoma (BCC and SCC) and tumorigenesis in response to chemical carcinogens (Brennan-
Crispi et al., 2015).  Dsg2 modulates exosome release from keratinocytes and induces pro-
proliferative activity in dermal fibroblasts (Overmiller et al., 2017).  These results indicate that 
Dsg2 can profoundly affect the homeostasis of the epidermis and facilitate skin carcinogenesis. 
In the epidermis, Dsg2 expression is restricted to the basal layer and decreases with age 
(Brennan and Mahoney, 2009, Schäfer et al., 1994).  Mutations in the human DSG2 gene are 
associated with fibrosis and cardiomyopathy with no obvious skin phenotype (Awad et al., 2006, 
Pilichou et al., 2006).  Dsg2 is downregulated in non-healing venous ulcers, though other 
desmosomal cadherins, including Dsc2 and Dsg3, are upregulated (Stojadinovic et al., 2008).  
Given that the proliferative and differentiating populations of keratinocytes in the epidermis are 
functionally distinct, we sought to determine the effects of Dsg2 overexpression in basal 
keratinocytes through K14-driven expression (K14-Dsg2).  The effect of basal Dsg2 on 
epidermal homeostasis, malignant transformation, and wound healing was investigated, and the 
results illustrate that basal keratinocytes overexpressing Dsg2 are ‘primed’ to maintain the 
epidermal architecture following tissue damage without inducing hyperplasticity in the skin.     
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RESULTS 
Establishment and characterization of K14-Dsg2 transgenic mice 
In the interfollicular epidermis, Dsg2 is barely detectable, and loss-of-function Dsg2lo/lo mice 
develop fibrotic lesions in the heart without skin morphological changes (Ebert et al., 2016).  To 
assess the role of Dsg2 in the epidermis, we generated a K14-Dsg2 construct by subcloning the 
C-terminal Flag-tagged mouse Dsg2 cDNA downstream of the human keratin 14 (KRT14) 
promoter (Figure S1a) (Brennan et al., 2007).  K14-Dsg2 transgenic mice did not exhibit any 
gross developmental, morphological, or life span defects compared to wild-type mice and litter 
sizes were normal (between 6-10 pups per litter).  We confirmed the expression of Dsg2 in the 
skin of these mice by immunoblotting (Figure 1a) and immunofluorescence for the Flag tag 
(Figure S1b).  The staining pattern of Flag-tagged Dsg2 was not continuous along the 
interfollicular epidermis and occasionally appeared to be cytoplasmic, similar to that of 
endogenous Dsg2 (Brennan and Mahoney, 2009).  As suprabasal expression of Dsg2 induced 
epidermal hyperplasia at all ages, the epidermis of K14-Dsg2 mice was evaluated. Surprisingly, 
K14-driven expression of Dsg2 did not induce any apparent changes in epidermal thickness 
(Figures 1b and S1c).  Furthermore, basal-Dsg2 did not alter keratinocyte proliferation, as 
measured by PCNA immunofluorescence (Figures S1d, e).  In summary, K14-driven expression 
of Dsg2 in the basal epidermis had no detectable gross morphological effects on mouse 
development, fecundity, or viability, and did not alter the overall architecture of the skin.   
Basal Dsg2 activates mitogenic and survival signaling pathways but does not increase 
susceptibility to chemical-induced carcinogenesis 
Dsg2 had been previously shown to positively regulate activation of the EGFR/MAPK signaling 
and other factors including c-myc, PI3K/AKT, c-Src, and STAT3 (Brennan et al., 2007, 
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Overmiller et al., 2016).  While the total levels of many signaling proteins including EGFR, 
STAT3, c-Raf, c-Src, and Cyclin D1 were increased in the transgenic mice, the level of c-Myc, a 
transcription factor that plays a critical role in keratinocyte proliferation was not affected (Figure 
1c) (Hirning et al., 1991, Mugrauer et al., 1988).  Next, we examined the phosphorylation of 
various mitogenic signaling proteins in the skin of K14-Dsg2 transgenic mice (Figure 1d).  
Remarkably, the K14-Dsg2 mice showed enhanced levels of phosphorylated EGFR, Src, c-Raf, 
AKT and PTEN. Furthermore, enhanced stabilization of activated β-catenin (Ctnnb1) and 
increased expression of the positive cell-cycle regulator Cyclin D1 (Ccnd1) was observed in 
K14-Dsg2 skin.  The increased expression of some of these factors in K14-Dsg2 epidermis was 
confirmed by specifically harvesting intact epidermal fractions from juvenile mice, as the 
epidermis is several cell layers thick and permissible to epidermal-dermal separation in young 
mice (Figure 1e). Signaling cascades, such as those downstream of EGFR, are activated in the 
developing skin as they are required for epidermal morphogenesis in perinatal mice—i.e. 
keratinocyte differentiation and hair follicle development/cycling (Schneider et al., 2008, 
Sotiropoulou and Blanpain, 2012). Though juvenile epidermis is mitotically active and 
undergoing rapid alterations, overexpression of Dsg2 potentiated the activation of various 
signaling cascades, but was unable to drive hyperplasia, even in this context (Figures 1b, S1c). 
Thus the results so far support our previous findings that Dsg2 can enhance mitogenic signaling, 
but appear to be insufficient to promote cell proliferation in the basal epidermis.  
Activated signaling in the K14-Dsg2 mice suggests that the skin is maintained in a 
‘primed’ homeostatic state. A similar phenomenon was observed in the epidermis of caveolin-1 
knockout mice which had no overt epidermal dysplasia, but were highly susceptible to DMBA-
TPA-induced tumorigenesis (Capozza et al., 2003). As many of these pathways drive early tumor 
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growth and are positively regulated by Dsg2, we next investigated tumor formation in K14-Dsg2 
mice. No sporadic epidermal lesions were observed in the epidermis of older transgenic mice (up 
to 9 months of age).  DMBA/TPA can drive the growth of mostly benign papillomas and, rarely, 
advanced squamous cell carcinomas after prolonged treatment (Filler et al., 2007). Wild-type and 
transgenic mice, following the DMBA/TPA treatment protocol, developed comparable 
hyperplasia in the dorsal epidermis and histopathologically similar tumors (Figure S2a, b). Both 
wild-type and transgenic mice developed an equal number of tumors larger than 2 mm (Figure 
S2c), which grew at the same rate (Figure S2d). These data illustrate that hyperactivation of 
signaling cascades in the skin of transgenic mice is insufficient to drive spontaneous and 
chemical carcinogenesis.     
Dsg2 overexpression accelerates cutaneous wound healing 
Aberrations in keratinocyte activation can dramatically disrupt proper wound healing (Barrientos 
et al., 2008). Therefore, we asked whether Dsg2 influences keratinocyte dynamics after 
wounding. Full-thickness wounds were inflicted on the dorsal skin of wild-type and K14-Dsg2 
transgenic mice and allowed to heal for up to four days (Figure 2a). The rate of wound closure in 
the transgenic mice was enhanced compared to the wild-type littermates (Figure 2b, c).  
Histologically, both wild-type and transgenic mouse wounds appeared similar with a dense 
lymphocytic infiltrate after wounding and similar reorganization of the dermis in regenerating 
tissue (Figures 2b and S3a). Keratinocyte proliferation is an important aspect of cutaneous 
wound healing, generally occurring at a later stage of the healing process (Pastar et al., 2014).  
Wounds from the K14-Dsg2 mice had more actively proliferating keratinocytes (Figure 2d).  
K14 expression in keratinocytes flanking and re-epithelializing the wound bed is a feature of 
normal cutaneous wound healing while K6 is a marker for activated keratinocytes, also highly 
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expressed in wound-adjacent keratinocytes (Freedberg et al., 2001, Schafer and Werner, 2008). 
K6 and K14 expression was observed 24 hours post-wounding in both wild-type and transgenic 
mice, but the expression of both keratins and Dsg2 itself was enhanced in the K14-Dsg2 wound-
adjacent keratinocytes (Figure S3b-d). These data illustrate that basal overexpression of Dsg2 
activates several pro-growth and cell division pathways that prime the skin for enhanced wound 
healing.  
Dsg2 alters secretion of wound healing-associated cytokines and chemokines 
Keratinocytes are exposed to and release soluble cytokines, chemokines, and growth factors 
secreted into the wound milieu to promote their migration and proliferation (Landen et al., 2016, 
Reinke and Sorg, 2012). To determine if Dsg2 could modulate the secretome of keratinocytes, 
we analyzed the conditioned media from HaCaT keratinocytes with a secretome antibody array.  
Dsg2 overexpression in HaCaTs altered the keratinocyte secretome with increases in the 
secretion of interleukin 6 receptor (IL-6R), urokinase plasminogen activator receptor (uPAR), 
and tumor necrosis factor receptor (TNFRI) (Figures 3a, b, S4a, and Table 1), cytokines that are 
critical for modulating the rate of wound repair by fibroblasts and keratinocytes (Behm et al., 
2012).  
uPAR plays a central role in cell surface-associated plasminogen activation leading to 
degradation and remodeling of the extracellular matrix (Ellis et al., 1989, Stephens et al., 1989). 
Loss of uPAR function in knockout mice showed delayed wound-healing response, and 
decreased keratinocytes proliferation and migration (D'Alessio et al., 2008). uPAR is a highly 
glycosylated, GPI-anchored receptor with 3 extracellular domains (D1-3).  Proteolytic cleavage 
can occur in the linker region between D1 and D2 to yield the uPARD2D3 fragment, which can 
undergo further cleavage of the GPI-linker releasing the soluble form uPARD2D3 (Sidenius et 
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al., 2000). Immunoblotting of lysates and immunohistochemistry of skin from wild-type and 
K14-Dsg2 transgenic mouse epidermis showed a significant increase in glycosylated (~55-70 
kDa) uPAR, soluble uPARD2D3 (~ 37 kDa) and full-length uPAR (~45 kDa) in response to 
Dsg2 overexpression (Figure 4a and b). HaCaTs overexpressing Dsg2 had enhanced expression 
of uPAR, and the dermis of transgenic mice had significant increases in the uPAR fragments 
(Figure S4b, c). Lysates from the day 1 wounds had increased uPAR expression and processing 
in the transgenic mice, corroborating uPAR immunostaining in wild-type and K14-Dsg2 
transgenic wounds (Figure S5a, b). The source of dermal uPAR could be from soluble full-length 
uPAR or uPARD2D3 from the epidermis, although we cannot rule out the release of uPAR from 
peri-wound dermal fibroblasts.  
Dsg2 enhances SCC cell migration in vitro in an EGFR- and c-Src-dependent fashion 
(Overmiller et al., 2016). HaCaTs stably overexpressing Dsg2 had similarly enhanced migration 
in an in vitro scratch assay, which was attenuated by blocking uPAR activity in the cells with an 
anti-uPAR antibody (Figure 4c). uPAR signaling induces downstream expression of laminin-332 
in keratinocytes in an EGFR-dependent manner (D'Alessio et al., 2008). Laminin-332 is a critical 
structural component of the basement membrane in healthy skin and is secreted by keratinocytes 
to promote cellular migration in re-epithelializing tissue (Iorio et al., 2015).  HaCaTs 
overexpressing Dsg2 had increased laminin-332 (Figure S4b).  The basal expression of laminin-
332 in healthy basement membranes was similar between wild-type and transgenic mice.  
Intriguingly, the transgenic wounds had more laminin-332 expression in the migrating 
keratinocytes and subsequently deposited in the regenerating basement membrane in a pattern 
similar to that seen in other mouse models of cutaneous wound repair (Figures 4d and S5c) 
(Jackow et al., 2016, Krampert et al., 2004, Veit et al., 2011).  uPAR can be secreted through 
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10 
exosomes, cell-derived vesicles of approximately 30-150 nm (Jung et al., 2009, Mu et al., 2013).  
We have previously shown Dsg2 potentiates the secretion of exosomes from both HaCaTs and 
malignant SCC cells (Overmiller et al., 2017). Indeed, both HaCaT+GFP and +Dsg2/GFP cells 
secreted exosomes equally enriched in a ~70kDa fraction of uPAR, likely corresponding to the 
full-length, highly glycosylated protein (Figure S5d). These results suggest that Dsg2 may 
facilitate wound repair through uPAR.   
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DISCUSSION  
Differentiation-dependent expression of various desmosomal cadherins in the epidermis may be 
an important factor for maintaining strata-specific cell-cell adhesion (Delva et al., 2009).  
However disruption of this expression pattern expression has revealed additional biological 
functions.  For example, forced expression of Dsg2 in the suprabasal epidermis of the Inv-Dsg2 
mice altered cell signaling and promoted cell growth and proliferation (Brennan et al., 2007).  
Interestingly, suprabasal expression of Dsg3 also induced epidermal hyperplasia and abnormal 
differentiation (Elias et al., 2001, Merritt et al., 2002).  In this report, overexpression of Dsg2 in 
the basal cell compartment of the epidermis was unable to disrupt tissue homeostasis. 
 Various mitogenic signaling pathways were significantly activated in the skin of K14-
Dsg2 transgenic mice, including ERK1/2, AKT, and β-catenin.  These pathways, when 
abnormally activated in the skin, typically drive epidermal hyperplasia and susceptibility to 
cutaneous malignancy (Dhillon et al., 2007, Hafner et al., 2010, Sherwood and Leigh, 2016). 
Furthermore, PTEN inactivation is a hallmark of various cancer types and is mutated in multiple 
hamartoma syndrome (Ming and He, 2009).  PTEN phosphorylation is associated with 
cytoplasmic sequestration and inhibition of its negative regulator role in the PI3K/AKT pathway 
(Das et al., 2003).  Though basal expression of Cyclin D1 was increased in our transgenic mice, 
knockout studies demonstrated that cyclin D1 alone is not sufficient to activate cell replication 
(Robles et al., 1998).  Similarly, while oncogenes such as STAT3 or c-Src play a critical role 
during cancer development, their role in the epidermis during normal homeostasis is poorly 
defined.  Interestingly, c-Myc expression was unaltered in the skin of K14-Dsg2 mice, in 
contrast to Inv-Dsg2 mice (Brennan et al., 2007).  Suprabasal overexpression of c-myc in mice 
resulted in hyperplasia while basal overexpression led to increased keratinocyte proliferation, but 
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attenuated migration during wound healing, due to β1 integrin transcriptional repression (Waikel 
et al., 2001, Waikel et al., 1999). It is possible that c-Myc may be the important driver of Dsg2-
induced epidermal hyperplasia that is not upregulated in K14-Dsg2 skin (Figure 5). Inducible 
knockout of c-Myc from basal keratinocytes delayed cutaneous wound healing and depleted the 
population of epidermal stem cells in a time-dependent manner (Zanet et al., 2005). Though 
overexpression of Dsg2 did not promote hyperplasia or tumor growth in response to 
DMBA/TPA treatment, Dsg2 in the basal keratinocytes accelerated cutaneous wound healing. 
Healing and regeneration in skin is an well-orchestrated event requiring keratinocyte 
proliferation and migration to completely cover and regenerate the wounded skin, with molecular 
signals such as cytokines and chemokines playing an essential role for restoration of tissue 
integrity (Gurtner et al., 2008). Though keratin patterning in the healthy epidermis is typified by 
basal keratins K5/K14 and differentiation keratins K1/K10, wound-adjacent keratinocytes 
express high levels of the activation marker K6 (Freedberg et al., 2001). The K14-Dsg2 
transgenic mice had enhanced expression of K6 following cutaneous injury suggesting that the 
cells, indolent in healthy skin, are indeed primed for activation and healing.  
Keratinocytes have long been recognized as a major source of growth factors and 
cytokines that are critical during wound healing, including uPA and uPAR (Werner and Grose, 
2003). There was increased uPAR expression in the epidermis and secretion into the dermis of 
the K14-Dsg2 mice as well as the actively proliferating and migrating keratinocytes adjacent to 
the wounded tissue. Overexpression of uPAR constitutively activates EGFR and c-Src to 
promote cell motility through α5β1 integrin, while loss of uPAR attenuates EGFR-dependent 
laminin-332 secretion without affecting integrin expression or signaling (D'Alessio et al., 2008, 
Tarui et al., 2003). While EGFR and Src are wholly capable of promoting hyperproliferation and 
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motility in keratinocytes independently, synergy with uPAR-related signaling could further 
stimulate this signaling cascade. Dsg2 enhances the release of uPAR into the dermis and wound 
area by two potential mechanisms (Figure 5). Phospholipase D (PLD), which is activated in 
wounded keratinocytes, cleaves the GPI anchor to release soluble uPAR (Arun et al., 2013).  
Proteinases further cleave within the linker region between domains D1 and D2. uPAR can also 
undergo endocytosis into endosomes and multivesicular bodies and, when fused with the plasma 
membrane, release uPAR-loaded exosomes. Though Dsg2 does not enhance the sorting of uPAR 
to exosomes, we have previously shown that both malignant and non-malignant keratinocytes 
overexpressing Dsg2 release more exosomes per cell (Overmiller et al., 2017). The cleaved 
uPAR in the extracellular milieu potentially promotes additional fibroblast activation and matrix 
remodeling in the healing dermis.   
Loss of uPAR in knockout mice disrupted wound repair by reducing laminin-332 
expression in an EGFR-dependent manner (D'Alessio et al., 2008).  We observed increased 
laminin-332 in the epithelial tongue of the healing wounds of transgenic mice. In the healthy 
epidermis, both EGFR and Src were hyperactivated in the transgenic mice, corroborating our 
previous in vitro findings (Overmiller et al., 2016). We postulate that uPAR may enhance cell 
growth and migration through its interaction with integrins and associated downstream signaling 
pathways including EGFR and c-Src (Ghosh et al., 2000, Xue et al., 1997). Indeed, these results 
suggest that EGFR/c-Src act in conjunction or synergize with the uPAR signaling axis to 
promote enhanced wound healing in our transgenic mouse model. c-Src itself is an upstream 
regulator of uPAR transcription, which may be an important intermediary for upregulating uPAR 
expression in the K14-Dsg2 mouse keratinocytes (Okan et al., 2001). In summary, these data 
demonstrate a broad effect of Dsg2 in priming basal keratinocytes mitogenic and pro-migratory 
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cellular signaling following trauma, at least in part by increased secretion of a panel of soluble 
factors that can enhance the repair program. 
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MATERIALS AND METHODS 
Details of protocols and reagents utilized can be found in the Supplementary Materials and 
Methods online. 
Ethics statement on animal research 
Animal experiments were facilitated within the guidelines provided within the Guide for the 
Care and Use of Laboratory Animals of the NIH and in accordance with Laboratory Animal 
Services at TJU. The animal usage protocol was approved by IACUC at TJU after review by the 
staff veterinarian. 
Generating transgenic mice and genotyping 
The Dsg2.Flag cDNA was subcloned into a targeting construct containing ~2,300 bp of the 
human cytokeratin KRT14 promoter and a polyadenylation tail (kind gift from Dr. Elaine Fuchs, 
Rockefeller University) (Brennan et al., 2007). Founder mice were backcrossed at least 5 
generations to the C57BL/6J inbred strain background for further analysis. 
Immunofluorescence and immunohistochemistry 
Sections (4 µm) of OCT (Tissue-Tek; Fisher) frozen tissues were immunostained for Flag, 
pEGFR (Tyr845), pSrc (Tyr416), Laminin-332, and Dsg2 and FFPE tissues for PCNA, K14, K6, 
and uPAR (Brennan et al., 2007).  
Keratinocyte proliferation 
Proliferation was assayed by immunostaining mouse skin for PCNA and DAPI.  The number of 
PCNA+ cells was counted in at least 3 random high-powered (40x) fields or a single, 
encompassing medium-powered (20x) field for the normal and wounded tissue, respectively.  
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DMBA-TPA-induced skin carcinogenesis  
Wild-type and K14-Dsg2 transgenic mice (6-8 weeks; male and female) were treated with 
DMBA (7,12-dimethylbenz[a]antracene) and biweekly applications of TPA (12-O-
tetradecanoylphorbol 13-acetate) to promote skin tumor growth (Brennan et al., 2007, Filler et 
al., 2007).  Tumors were measured biweekly using digital calipers.  
Full-thickness skin wounding  
Punch biopsies (4 mm) were used to generate wounds in wild-type and K14-Dsg2 transgenic 
mice (6-8 weeks; male and female) (Wang et al., 2013).  Wounds were photographed daily by 
digital microscope (Plugable USB 2.0 Digital Microscope). 
Cytokine antibody array  
Cytokine profiles of conditioned media (48 h) from HaCaT-GFP and HaCaT-Dsg2/GFP cells 
were analyzed using a Human Cytokine Antibody Array C1000 (#AAH-CYT-1000-2; 
Raybiotech, Norcross, GA).  Quantification of dot intensity was performed in ImageJ following 
background subtraction, and the raw data normalized to the array-specific positive control dots. 
Scratch Assay 
Confluent HaCaT+GFP and +Dsg2/GFP sheets were scratched with a P200 pipet tip and 
incubated 24 hr in DMEM ± 1 µg/mL anti-uPAR antibody. Images were taken immediately post-
scratch and 24 hr later; data expressed as % of initial width between epithelial sheets remaining.  
Exosome isolation  
Exosomes were purified from conditioned medium of HaCaT keratinocytes by sequential 
ultracentrifugation (Greening et al., 2015, Overmiller et al., 2017). Medium was centrifuged at 
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300 x g, 2,000 x g, and 10,000 x g to remove live and dead cells, and microvesicles. Supernatant 
was centrifuged at 110,000 x g (Beckman 45Ti) to pellet exosomes. 
Statistical analysis  
Data are expressed average value ± SEM. Student’s t test, unless otherwise noted in 
Supplemental Materials and Methods * p<0.05; ** p<0.01; *** p<0.001. 
  
M
A
N
U
S
C
R
IP
T
 
A
C
C
E
P
T
E
D
ACCEPTED MANUSCRIPT
 
 
18 
ORCID 
My Mahoney: 0000-0003-0203-9171 
CONFLICT OF INTEREST 
The authors have declared that no conflict of interest exists. 
ACKNOWLEDGEMENTS  
Research reported here was supported by the NIH (Mahoney, AR056067), the Sidney Kimmel 
Cancer Center (Mahoney), and the Thomas Jefferson University Dean’s Transformational 
Science Award (Mahoney).  
AUTHOR CONTRIBUTIONS 
FC, AMO, DMB, MGM were involved in the study design and concept. LDS, JKW, and MGM 
provided reagents. FC, AMO, AL, DMB, KPM, MRM, LDS and MGM were involved in data 
acquisition. FC, AMO, DMB, KPM, MRM, NAR-D, JKW and MGM were involved in data 
analysis and interpretation. AMO, FC and MGM drafted the manuscript. FC, AMO, DMB, 
NAR-D, LDS, JKW, and MGM edited the manuscript. 
  
M
A
N
U
S
C
R
IP
T
 
A
C
C
E
P
T
E
D
ACCEPTED MANUSCRIPT
 
 
19 
REFERENCES 
Aomatsu K, Arao T, Abe K, Kodama A, Sugioka K, Matsumoto K, et al. Slug is upregulated 
during wound healing and regulates cellular phenotypes in corneal epithelial cells. Invest 
Ophthalmol Vis Sci 2012;53(2):751-6. 
Arun SN, Xie D, Howard AC, Zhong Q, Zhong X, McNeil PL, et al. Cell wounding activates 
phospholipase D in primary mouse keratinocytes. J Lipid Res 2013;54(3):581-91. 
Awad MM, Dalal D, Cho E, Amat-Alarcon N, James C, Tichnell C, et al. DSG2 mutations 
contribute to arrhythmogenic right ventricular dysplasia/cardiomyopathy. Am j hum genet 
2006;79(1):136-42. 
Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M. Growth factors and 
cytokines in wound healing. Wound Repair Regen 2008;16(5):585-601. 
Behm B, Babilas P, Landthaler M, Schreml S. Cytokines, chemokines and growth factors in 
wound healing. J Eur Acad Dermatol Venereol 2012;26(7):812-20. 
Brennan-Crispi DM, Hossain C, Sahu J, Brady M, Riobo NA, Mahoney MG. Crosstalk between 
Desmoglein 2 and Patched 1 accelerates chemical-induced skin tumorigenesis. Oncotarget 
2015;6(11):8593-605. 
Brennan D, Hu Y, Joubeh S, Choi YW, Whitaker-Menezes D, O’Brien T, et al. Suprabasal Dsg2 
expression in transgenic mouse skin confers a hyperproliferative and apoptosis-resistant 
phenotype to keratinocytes. J Cell Science 2007;120(5):758-71. 
Brennan D, Mahoney MG. Increased expression of Dsg2 in malignant skin carcinomas: A tissue-
microarray based study. Cell Adh Migr 2009;3(2):148-54. 
Brennan D, Peltonen S, Dowling A, Medhat W, Green KJ, Wahl JK, et al. A role for caveolin-1 
in desmoglein binding and desmosome dynamics. Oncogene 2012;31(13):1636-48. 
Capozza F, Williams TM, Schubert W, McClain S, Bouzahzah B, Sotgia F, et al. Absence of 
caveolin-1 sensitizes mouse skin to carcinogen-induced epidermal hyperplasia and tumor 
formation. Am J Pathol 2003;162(6):2029-39. 
D'Alessio S, Gerasi L, Blasi F. uPAR-deficient mouse keratinocytes fail to produce EGFR-
dependent laminin-5, affecting migration in vivo and in vitro. J Cell Sci 2008;121(Pt 23):3922-
32. 
Das S, Dixon JE, Cho W. Membrane-binding and activation mechanism of PTEN. Proc Natl 
Acad Sci U S A 2003;100(13):7491-6. 
Delva E, Tucker DK, Kowalczyk AP. The desmosome. Cold Spring Harb Perspect Biol 
2009;1(2):a002543. 
M
A
N
U
S
C
R
IP
T
 
A
C
C
E
P
T
E
D
ACCEPTED MANUSCRIPT
 
 
20 
Dhillon AS, Hagan S, Rath O, Kolch W. MAP kinase signalling pathways in cancer. Oncogene 
2007;26(22):3279-90. 
Dhouailly D, Sawyer RH. Avian scale development. XI. Initial appearance of the dermal defect 
in scaleless skin. Dev Biol 1984;105(2):343-50. 
Elias PM, Matsuyoshi N, Wu H, Lin C, Wang ZH, Brown BE, et al. Desmoglein isoform 
distribution affects stratum corneum structure and function. J Cell Biol 2001;153(2):243-9. 
Ellis V, Scully MF, Kakkar VV. Plasminogen activation initiated by single-chain urokinase-type 
plasminogen activator. Potentiation by U937 monocytes. J Biol Chem 1989;264(4):2185-8. 
Eshkind L, Tian Q, Schmidt A, Franke WW, Windoffer R, Leube RE. Loss of desmoglein 2 
suggests essential functions for early embryonic development and proliferation of embryonal 
stem cells. Eur J Cell Biol 2002;81:592-8. 
Filler RB, Roberts SJ, Girardi M. Cutaneous two-stage chemical carcinogenesis. CSH Protoc 
2007;2007:pdb prot4837. 
Freedberg IM, Tomic-Canic M, Komine M, Blumenberg M. Keratins and the keratinocyte 
activation cycle. J Invest Dermatol 2001;116(5):633-40. 
Ghosh S, Brown R, Jones JC, Ellerbroek SM, Stack MS. Urinary-type plasminogen activator 
(uPA) expression and uPA receptor localization are regulated by alpha 3beta 1 integrin in oral 
keratinocytes. J Biol Chem 2000;275(31):23869-76. 
Greening DW, Xu R, Ji H, Tauro BJ, Simpson RJ. A protocol for exosome isolation and 
characterization: evaluation of ultracentrifugation, density-gradient separation, and 
immunoaffinity capture methods. Methods Mol Biol 2015;1295:179-209. 
Gurtner GC, Werner S, Barrandon Y, Longaker MT. Wound repair and regeneration. Nature 
2008;453(7193):314-21. 
Hafner C, Landthaler M, Vogt T. Activation of the PI3K/AKT signalling pathway in non-
melanoma skin cancer is not mediated by oncogenic PIK3CA and AKT1 hotspot mutations. Exp 
Dermatol 2010;19(8):e222-7. 
Hirning U, Schmid P, Schulz WA, Rettenberger G, Hameister H. A comparative analysis of N-
myc and c-myc expression and cellular proliferation in mouse organogenesis. Mech Dev 
1991;33(2):119-25. 
Iorio V, Troughton LD, Hamill KJ. Laminins: Roles and Utility in Wound Repair. Adv Wound 
Care (New Rochelle) 2015;4(4):250-63. 
Jackow J, Loffek S, Nystrom A, Bruckner-Tuderman L, Franzke CW. Collagen XVII Shedding 
Suppresses Re-Epithelialization by Directing Keratinocyte Migration and Dampening mTOR 
Signaling. J Invest Dermatol 2016;136(5):1031-41. 
M
A
N
U
S
C
R
IP
T
 
A
C
C
E
P
T
E
D
ACCEPTED MANUSCRIPT
 
 
21 
Jung T, Castellana D, Klingbeil P, Cuesta Hernandez I, Vitacolonna M, Orlicky DJ, et al. 
CD44v6 dependence of premetastatic niche preparation by exosomes. Neoplasia 
2009;11(10):1093-105. 
Klessner JL, Desai BV, Amargo EV, Getsios S, Green KJ. EGFR and ADAMs cooperate to 
regulate shedding and endocytic trafficking of the desmosomal cadherin desmoglein 2. Mol Biol 
Cell 2009;20(1):328-37. 
Kowalczyk AP, Green KJ. Structure, function, and regulation of desmosomes. . Prog Mol Biol 
Transl Sci 2013;116:95-118. 
Krampert M, Bloch W, Sasaki T, Bugnon P, Rulicke T, Wolf E, et al. Activities of the matrix 
metalloproteinase stromelysin-2 (MMP-10) in matrix degradation and keratinocyte organization 
in wounded skin. Mol Biol Cell 2004;15(12):5242-54. 
Landen NX, Li D, Stahle M. Transition from inflammation to proliferation: a critical step during 
wound healing. Cell Mol Life Sci 2016;73(20):3861-85. 
Lechler T, Fuchs E. Asymmetric cell divisions promote stratification and differentiation of 
mammalian skin. Nature 2005;437(7056):275-80. 
McGowan K, Coulombe P. The wound repair-associated keratins 6, 16, and 17. Insights into the 
role of intermediate filaments in specifying keratinocyte cytoarchitecture. Herrmann H, Harris 
JR, editors. New York: Plenum Press, 1998. 173-204 p. 
Merritt AJ, Berika MY, Zhai W, Kirk SE, Ji B, Hardman MJ, et al. Suprabasal desmoglein 3 
expression in the epidermis of transgenic mice results in hyperproliferation and abnormal 
differentiation. Mol Cell Biol 2002;22(16):5846-58. 
Ming M, He YY. PTEN: new insights into its regulation and function in skin cancer. J Invest 
Dermatol 2009;129(9):2109-12. 
Mu W, Rana S, Zoller M. Host matrix modulation by tumor exosomes promotes motility and 
invasiveness. Neoplasia 2013;15(8):875-87. 
Mugrauer G, Alt FW, Ekblom P. N-myc proto-oncogene expression during organogenesis in the 
developing mouse as revealed by in situ hybridization. J Cell Biol 1988;107(4):1325-35. 
Okan E, Drewett V, Shaw PE, Jones P. The small-GTPase RalA activates transcription of the 
urokinase plasminogen activator receptor (uPAR) gene via an AP1-dependent mechanism. 
Oncogene 2001;20(15):1816-24. 
Overmiller AM, McGuinn KP, Roberts BJ, Cooper F, Brennan-Crispi DM, Deguchi T, et al. c-
Src/Cav1-dependent activation of the EGFR by Dsg2. Oncotarget 2016;7(25):37536-55. 
Overmiller AM, Pierluissi JA, Wermuth PJ, Sauma S, Martinez-Outschoorn U, Tuluc M, et al. 
Desmoglein 2 modulates extracellular vesicle release from squamous cell carcinoma 
keratinocytes. FASEB J 2017;31(8):3412-24. 
M
A
N
U
S
C
R
IP
T
 
A
C
C
E
P
T
E
D
ACCEPTED MANUSCRIPT
 
 
22 
Pastar I, Stojadinovic O, Yin NC, Ramirez H, Nusbaum AG, Sawaya A, et al. Epithelialization in 
Wound Healing: A Comprehensive Review. Adv Wound Care (New Rochelle) 2014;3(7):445-
64. 
Pilichou K, Nava A, Basso C, Beffagna G, Bauce B, Lorenzon A, et al. Mutations in 
desmoglein-2 gene are associated with arrhythmogenic right ventricular cardiomyopathy. 
Circulation 2006;113(9):1171-9. 
Reinke JM, Sorg H. Wound repair and regeneration. Eur Surg Res 2012;49(1):35-43. 
Robles AI, Rodriguez-Puebla ML, Glick AB, Trempus C, Hansen L, Sicinski P, et al. Reduced 
skin tumor development in cyclin D1-deficient mice highlights the oncogenic ras pathway in 
vivo. Genes Dev 1998;12(16):2469-74. 
Roshan A, Murai K, Fowler J, Simons BD, Nikolaidou-Neokosmidou V, Jones PH. Human 
keratinocytes have two interconvertible modes of proliferation. Nat Cell Biol 2016;18(2):145-56. 
Schafer M, Werner S. Cancer as an overhealing wound: an old hypothesis revisited. Nat Rev Mol 
Cell Biol 2008;9(8):628-38. 
Schäfer S, Koch PJ, Franke WW. Identification of the ubiquitous human desmoglein, Dsg2, and 
the expression catalogue of the desmoglein subfamily of desmosomal cadherins. Exp Cell Res 
1994;211:391-9. 
Schneider MR, Werner S, Paus R, Wolf E. Beyond wavy hairs: the epidermal growth factor 
receptor and its ligands in skin biology and pathology. Am J Pathol 2008;173(1):14-24. 
Sherwood V, Leigh IM. WNT Signaling in Cutaneous Squamous Cell Carcinoma: A Future 
Treatment Strategy? J Invest Dermatol 2016;136(9):1760-7. 
Sidenius N, Sier CF, Blasi F. Shedding and cleavage of the urokinase receptor (uPAR): 
identification and characterisation of uPAR fragments in vitro and in vivo. FEBS Lett 
2000;475(1):52-6. 
Sotiropoulou PA, Blanpain C. Development and homeostasis of the skin epidermis. Cold Spring 
Harb Perspect Biol 2012;4(7):a008383. 
Stephens RW, Pollanen J, Tapiovaara H, Leung KC, Sim PS, Salonen EM, et al. Activation of 
pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-
bound reactants. J Cell Biol 1989;108(5):1987-95. 
Stojadinovic O, Pastar I, Vukelic S, Mahoney MG, Brennan D, Krzyzanowska A, et al. 
Deregulation of keratinocyte differentiation and activation: a hallmark of venous ulcers. J Cell 
Mol Med 2008;12(6B):2675-90. 
Tarui T, Andronicos N, Czekay RP, Mazar AP, Bdeir K, Parry GC, et al. Critical role of integrin 
alpha 5 beta 1 in urokinase (uPA)/urokinase receptor (uPAR, CD87) signaling. J Biol Chem 
2003;278(32):29863-72. 
M
A
N
U
S
C
R
IP
T
 
A
C
C
E
P
T
E
D
ACCEPTED MANUSCRIPT
 
 
23 
Veit G, Zwolanek D, Eckes B, Niland S, Kapyla J, Zweers MC, et al. Collagen XXIII, novel 
ligand for integrin alpha2beta1 in the epidermis. J Biol Chem 2011;286(31):27804-13. 
Waikel RL, Kawachi Y, Waikel PA, Wang XJ, Roop DR. Deregulated expression of c-Myc 
depletes epidermal stem cells. Nat Genet 2001;28(2):165-8. 
Waikel RL, Wang XJ, Roop DR. Targeted expression of c-Myc in the epidermis alters normal 
proliferation, differentiation and UV-B induced apoptosis. Oncogene 1999;18:4870-8. 
Wang X, Ge J, Tredget EE, Wu Y. The mouse excisional wound splinting model, including 
applications for stem cell transplantation. Nat Protoc 2013;8(2):302-9. 
Werner S, Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev 
2003;83(3):835-70. 
Xue W, Mizukami I, Todd RF, 3rd, Petty HR. Urokinase-type plasminogen activator receptors 
associate with beta1 and beta3 integrins of fibrosarcoma cells: dependence on extracellular 
matrix components. Cancer Res 1997;57(9):1682-9. 
Zanet J, Pibre S, Jacquet C, Ramirez A, de Alboran IM, Gandarillas A. Endogenous Myc 
controls mammalian epidermal cell size, hyperproliferation, endoreplication and stem cell 
amplification. J Cell Sci 2005;118(8):1693-704. 
 
  
M
A
N
U
S
C
R
IP
T
 
A
C
C
E
P
T
E
D
ACCEPTED MANUSCRIPT
 
 
24 
FIGURE LEGENDS 
Figure 1. Dsg2 enhances activation of mitogenic signaling species.  (a) Skin from wild-type 
and K14-Dsg2 transgenic mice was lysed and immunoblotted for Flag. (b) Representative 
hematoxylin and eosin staining of newborn, 14 day, and 6 week old dorsal skin of wild-type and 
transgenic mice.  (c) Dorsal skin from wild-type and transgenic mice was lysed and proteins 
were immunoblotted for phosphorylated or total signaling proteins.  Representative results from 
one of three independent experiments shown. (d) The signals were quantified and 
unphosphorylated proteins were normalized to GAPDH loading control while phosphorylated 
proteins were normalized to respective total proteins. (e) Wild-type and K14-Dsg2 mouse 
epidermis was immunoblotted for phosphorylated and total proteins. Data are depicted as 
percentage of wild-type and average ± SEM. N=3. 
Figure 2. Dsg2 promotes cutaneous wound healing.  (a) Full-thickness wounds were inflicted 
on the dorsal skin of wild-type and K14-Dsg2 transgenic mice and photographed up to 4 days 
post-wounding.  Space between blue ruler lines is 1 mm. (b) H&E staining of 4-day old wild-
type and transgenic wounds.  Dashed lines demarcate wound edge.  Scale bar=100 µm (c) 
Wound area of non-epithelialized tissue was measured in ImageJ (mm2) and normalized to the 
area of fresh wounds.  Data are expressed as average relative area of re-epithelialized tissue 
covering the initial wound (mm2) ± SEM.  N=13 wild-type; 16 transgenic.  (d) Representative 
immunofluorescence of wound-adjacent wild-type and transgenic mouse skin 4 days post 
wounding for PCNA (green) and DAPI (blue). Scale bars=50 µm.  
Figure 3. Cytokine profiling identifies uPAR as a key molecule upregulated in response to 
Dsg2. (a) Human Cytokine Antibody Arrays C6 and C7 were assayed with conditioned medium 
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from HaCaT keratinocytes overexpressing GFP or Dsg2/GFP.  Boxes indicate cytokines that 
showed statistically significant changes (dashed lines: downregulated; solid lines: upregulated). 
(b) Densitometry was performed of each cytokine by ImageJ software and histogram bars 
represent the relative intensity value of each cytokine secreted (white: HaCaT-GFP; black: 
HaCaT-Dsg2/GFP). Data are normalized to on-membrane positive control and depicted as 
relative abundancy in samples ± SEM. N=2.  
Figure 4. Dsg2 enhances epidermal and dermal uPAR in wounded tissues. (a) Wild-type and 
K14-Dsg2 transgenic mouse epidermis (N=3) was immunoblotted for uPAR and actin.  Signals 
were quantified, normalized to actin, and expressed as % of wild-type (right).  G-uPAR: 
glycosylated uPAR; uPAR: non-glycosylated uPAR; uPARD2D3: D2D3 domains of uPAR. (b)  
Wild-type and K14-Dsg2 transgenic mice skins were immunostained for uPAR. (c) HaCaT+GFP 
or +Dsg2/GFP were treated with 1µg/mL anti-uPAR antibody and allowed to migrate for 24 h 
following scratch. Data are normalized to initial wound width of respective conditions and 
expressed as % distance remaining to be re-epithelialized. N=3. (d) Wild-type and K14-Dsg2 
wounds (day 1) were immunostained for Laminin-332. Dashed line: regenerating basement 
membrane. Scale bars=50 µm. 
Figure 5. Dsg2 potentiates the wound healing response. (Top) Basal overexpression of Dsg2 
drives activation of various signaling cascade, but not overexpression of c-Myc, presumably 
leaving the epidermis primed, but unperturbed. Additionally, there is increased epidermal and 
dermal uPAR expression. (Bottom) During wound healing, uPAR can be shed and processed 
from the keratinocytes membranes as soluble uPAR (suPAR) and the D2D3 fragment, 
respectively. uPAR can also be shed via exosomes after shuttling through the endosomal sorting 
pathway; both mechanisms increase dermal uPAR concentration and promote matrix remodeling 
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and wound resolution. Through uPAR-mediated signaling, Dsg2 potentiates expression of pro-
migratory laminin-332 in the regenerating basement membrane. 
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Table 1. Cytokines altered in keratinocytes in response 
to Dsg2 (HaCaT-Dsg2/GFP / HaCaT-GFP) 
Cytokines Fold change P-value 
IL-6R 1.48 * 
uPAR 1.37 * 
TNFRI 1.18 * 
TIMP-2 -1.29 * 
GRO α/β/γ -1.28 * 
MCP-1 (CCL2) -1.32 *** 
RANTES (CCL5) -1.57 * 
PDGF-BB -1.59 * 
HaCaT: spontaneously transformed immortal keratinocytes; Dsg2: 
desmoglein 2; GFP: green fluorescence protein; IL-6R: 
interleukin-6 receptor; uPAR: urokinase-type plasminogen 
activator receptor; TNFRI: tumor necrosis factor receptor I; TIMP-
2: tissue inhibitor of metalloproteinase 2; GRO a/b/g: growth-
related oncogene; MCP-1/CCL2: monocyte chemoattractant 
protein 1/C-C motif chemokine 2; RANTES: regulated on 
activation, normal T cell expressed and secreted; PDGF-BB: 
Platelet-derived growth factor subunit B. *P< 0.05, ***P < 0.001 
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